Evidence map›Paper›PMID 31798681›Full record

ArticleInfectious agents and cancer2019

Cancer cases detected in the prevention and control service of a private cancer clinic in Peru.

José Revilla-López, Andrea Anampa-Guzmán, Luis Casanova Marquez, Katrina Weeks, Suzanne Pollard, Adriel Olórtegui-Yzú, María Ruiz-Velazco, Alba Davila-Edquen, Daniel Castro-Dorer, Juan Wong-Barrenechea and 4 more

Erratum issuedAbstract read
In one paragraph

Article in Infectious agents and cancer, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

José Revilla-López *Cancer Prevention and Control Service, ALIADA Contra el Cáncer, Lima, Peru.
Andrea Anampa-Guzmán *2Faculty of Medicine, Universidad Nacional Mayor de San Marcos, Lima, Peru.ORCID 0000-0002-4292-1137
Luis Casanova MarquezDeparment of Medical Oncology, ALIADA contra el cáncer, Lima, Peru.
Katrina Weeks4Department of International Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, USA.
Suzanne Pollard4Department of International Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, USA.
Adriel Olórtegui-Yzú5Department of Preventive Medicine and Public Health, Universidad Nacional Mayor de San Marcos, Lima, Peru.
María Ruiz-VelazcoCancer Prevention and Control Service, ALIADA Contra el Cáncer, Lima, Peru.
Alba Davila-EdquenCancer Prevention and Control Service, ALIADA Contra el Cáncer, Lima, Peru.
Daniel Castro-DorerCancer Prevention and Control Service, ALIADA Contra el Cáncer, Lima, Peru.
Juan Wong-BarrenecheaCancer Prevention and Control Service, ALIADA Contra el Cáncer, Lima, Peru.
Jossira Abad-SeminarioCancer Prevention and Control Service, ALIADA Contra el Cáncer, Lima, Peru.
Pamela Gonzáles-RamosCancer Prevention and Control Service, ALIADA Contra el Cáncer, Lima, Peru.
Fiorella Rivera-SandovalCancer Prevention and Control Service, ALIADA Contra el Cáncer, Lima, Peru.
Carlos Carracedo-GonzálesGeneral Medical Council, ALIADA Contra el Cáncer, Lima, Peru.

Funding

A multi-faceted intervention to promote adoption of clean fuel technologies for respiratory health in PeruK01HL140048 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI POLLARD, SUZANNE · 2018 to 2021
$462k
NHLBI NIH HHS K01 HL140048
6 · The paper itself

Abstract

purposeDescribe the characteristics of patients seen at the Cancer Prevention and Control Service at a Peruvian private cancer clinic in 2014. PATIENTS AND

methodsThis retrospective clinical study analyzed the prevalence of 10 cancers and characteristics of patients seen at a private cancer center located in Lima, Peru. The study sample included 7680 adults, and data were collected from de-identified medical records.

resultsThe average age of the patients was 44.71 years and 98,82% of them had private insurance. The majority of patients were women (67.69%). Our gross incidence rate of cancer was 35.16 per 100,000 in the Cancer Prevention and Control Service in 2014. Only 0.35% had cancer, and most of those diagnosed with cancer (77.78%) were diagnosed in the early stages, stages I and II. The two most common cancers observed were breast and thyroid cancer.

conclusionsThe high rates of early, rather than late-stage diagnoses at this clinic are dramatically different than national rates. This difference may be because we are analyzing data from a prevention service seeing mainly patients with private insurance as opposed to national data, which consists primarily of patients seen in oncologic services with national insurance.

Indexed as

DiagnosisEarly detection of cancerMass screeningOncology

Identifiers

PMID31798681
PMCPMC6884821

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.